Equities Analysts Offer Predictions for RLI Q1 Earnings

RLI Corp. (NYSE:RLIFree Report) – Analysts at Zacks Research cut their Q1 2026 earnings per share (EPS) estimates for shares of RLI in a research note issued on Monday, March 24th. Zacks Research analyst T. De now expects that the insurance provider will post earnings per share of $0.75 for the quarter, down from their previous forecast of $0.76. The consensus estimate for RLI’s current full-year earnings is $3.08 per share.

A number of other research analysts have also recently commented on the company. JMP Securities reaffirmed a “market perform” rating on shares of RLI in a research note on Thursday, January 23rd. Jefferies Financial Group lowered shares of RLI from a “buy” rating to an “underperform” rating and lowered their target price for the company from $95.00 to $61.00 in a research note on Monday, January 27th. Compass Point cut their price target on shares of RLI from $185.00 to $82.00 and set a “buy” rating on the stock in a report on Monday, January 27th. StockNews.com upgraded shares of RLI from a “sell” rating to a “hold” rating in a report on Friday, February 21st. Finally, Keefe, Bruyette & Woods dropped their target price on shares of RLI from $100.50 to $100.00 and set an “outperform” rating on the stock in a research note on Friday, January 10th. One research analyst has rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $82.80.

Check Out Our Latest Analysis on RLI

RLI Stock Performance

Shares of NYSE:RLI opened at $79.27 on Thursday. The company has a current ratio of 0.34, a quick ratio of 0.38 and a debt-to-equity ratio of 0.07. RLI has a 12 month low of $67.53 and a 12 month high of $91.15. The company has a market capitalization of $7.27 billion, a price-to-earnings ratio of 21.17 and a beta of 0.39. The firm’s 50-day moving average is $75.59 and its 200 day moving average is $79.36.

RLI (NYSE:RLIGet Free Report) last posted its quarterly earnings data on Wednesday, January 22nd. The insurance provider reported $0.41 EPS for the quarter, missing the consensus estimate of $1.05 by ($0.64). RLI had a return on equity of 16.63% and a net margin of 19.53%.

RLI Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, March 20th. Shareholders of record on Friday, February 28th were given a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 0.76%. The ex-dividend date was Friday, February 28th. This is a boost from RLI’s previous quarterly dividend of $0.15. RLI’s dividend payout ratio (DPR) is 16.00%.

Insider Activity

In other news, Director Robert P. Restrepo, Jr. sold 2,864 shares of the company’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $74.89, for a total transaction of $214,484.96. Following the transaction, the director now directly owns 23,312 shares of the company’s stock, valued at approximately $1,745,835.68. This represents a 10.94 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Jeffrey D. Fick acquired 2,000 shares of the stock in a transaction dated Friday, January 24th. The stock was acquired at an average cost of $72.13 per share, with a total value of $144,260.00. Following the transaction, the insider now directly owns 142,061 shares in the company, valued at approximately $10,246,859.93. This represents a 1.43 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have purchased 11,200 shares of company stock worth $805,774. 5.09% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On RLI

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Brown Brothers Harriman & Co. increased its holdings in shares of RLI by 0.8% during the third quarter. Brown Brothers Harriman & Co. now owns 7,879 shares of the insurance provider’s stock valued at $1,221,000 after acquiring an additional 66 shares in the last quarter. Versant Capital Management Inc grew its position in RLI by 53.8% during the 4th quarter. Versant Capital Management Inc now owns 203 shares of the insurance provider’s stock worth $33,000 after purchasing an additional 71 shares during the last quarter. Nomura Asset Management Co. Ltd. raised its holdings in shares of RLI by 76.9% in the third quarter. Nomura Asset Management Co. Ltd. now owns 230 shares of the insurance provider’s stock worth $36,000 after buying an additional 100 shares during the last quarter. SkyView Investment Advisors LLC lifted its stake in shares of RLI by 2.3% during the third quarter. SkyView Investment Advisors LLC now owns 4,545 shares of the insurance provider’s stock worth $704,000 after buying an additional 103 shares during the period. Finally, Brookstone Capital Management grew its holdings in shares of RLI by 7.5% during the fourth quarter. Brookstone Capital Management now owns 1,827 shares of the insurance provider’s stock valued at $301,000 after buying an additional 127 shares during the last quarter. 77.89% of the stock is currently owned by hedge funds and other institutional investors.

RLI Company Profile

(Get Free Report)

RLI Corp., an insurance holding company, underwrites property and casualty insurance. Its Casualty segment provides commercial and personal coverage products; and general liability products, such as coverage for third-party liability of commercial insureds, including manufacturers, contractors, apartments, and mercantile.

Further Reading

Earnings History and Estimates for RLI (NYSE:RLI)

Receive News & Ratings for RLI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RLI and related companies with MarketBeat.com's FREE daily email newsletter.